| 7.4 0.09 (1.23%) | 06-16 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 10.51 | 1-year : | 12.27 |
| Resists | First : | 9 | Second : | 10.51 |
| Pivot price | 7.32 |
|||
| Supports | First : | 6.02 | Second : | 4.17 |
| MAs | MA(5) : | 7.11 |
MA(20) : | 6.88 |
| MA(100) : | 4.16 |
MA(250) : | 7.88  |
|
| MACD | MACD : | 0.4 |
Signal : | 0.5 |
| %K %D | K(14,3) : | 50 |
D(3) : | 50.3 |
| RSI | RSI(14): 56.5 |
|||
| 52-week | High : | 32.09 | Low : | 1.02 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ AGPU ] has closed below upper band by 47.0%. Bollinger Bands are 24% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 8.01 - 8.04 | 8.04 - 8.07 |
| Low: | 7.03 - 7.06 | 7.06 - 7.1 |
| Close: | 7.35 - 7.4 | 7.4 - 7.45 |
Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.
Tue, 16 Jun 2026
Axe Compute signs $25.9M in AI deployments - Proactive financial news
Tue, 16 Jun 2026
Axe Compute (AGPU) Secures $25.9M in Contracts for AI Solutions - GuruFocus
Tue, 16 Jun 2026
Axe Compute Inc. Secures $25.9 Million in Contracts for Long-Term Deployments of Blackwell and Grace Blackwell Compute - marketscreener.com
Tue, 16 Jun 2026
Axe Compute Inc. Secures $25.9 Million in Long-Term Contracts to Expand AI Infrastructure Services - Quiver Quantitative
Tue, 16 Jun 2026
Axe Compute Secures $25.9 Million in Contracts for Long-Term Deployments of Blackwell and Grace Blackwell Compute - The Manila Times
Tue, 16 Jun 2026
AI clients lock in $25.9M of Axe Compute Blackwell capacity - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Technology
|
|
|
Industry:
Software - Infrastructure
|
|
| Shares Out | 0 (M) |
| Shares Float | 11 (M) |
| Held by Insiders | 3.63e+006 (%) |
| Held by Institutions | 12.8 (%) |
| Shares Short | 209 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -2.83e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -232 % |
| Return on Assets (ttm) | 861.2 % |
| Return on Equity (ttm) | -61.5 % |
| Qtrly Rev. Growth | 125280 % |
| Gross Profit (p.s.) | -0.38 |
| Sales Per Share | -281.65 |
| EBITDA (p.s.) | 15132.2 |
| Qtrly Earnings Growth | -9 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -10 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.03 |
| Price to Cash Flow | 2.2 |
| Dividend | 0 |
| Forward Dividend | 298810 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|